129 related articles for article (PubMed ID: 20097627)
1. [Macrophage activation syndrome and systemic onset of juvenile idiopathic arthritis].
Iglesias Jiménez E; Camacho Lovillo MS; Lirola Cruz MJ; Falcón Neyra D; Neth O
An Pediatr (Barc); 2010 Mar; 72(3):230-1. PubMed ID: 20097627
[No Abstract] [Full Text] [Related]
2. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Davì S; Consolaro A; Guseinova D; Pistorio A; Ruperto N; Martini A; Cron RQ; Ravelli A;
J Rheumatol; 2011 Apr; 38(4):764-8. PubMed ID: 21285158
[TBL] [Abstract][Full Text] [Related]
3. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis.
Yanagimachi M; Naruto T; Miyamae T; Hara T; Kikuchi M; Hara R; Imagawa T; Mori M; Sato H; Goto H; Yokota S
J Rheumatol; 2011 Apr; 38(4):769-74. PubMed ID: 21239750
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.
Vastert SJ; van Wijk R; D'Urbano LE; de Vooght KM; de Jager W; Ravelli A; Magni-Manzoni S; Insalaco A; Cortis E; van Solinge WW; Prakken BJ; Wulffraat NM; de Benedetti F; Kuis W
Rheumatology (Oxford); 2010 Mar; 49(3):441-9. PubMed ID: 20019066
[TBL] [Abstract][Full Text] [Related]
5. Recognition and management of macrophage activation syndrome in juvenile arthritis.
Kelly A; Ramanan AV
Curr Opin Rheumatol; 2007 Sep; 19(5):477-81. PubMed ID: 17762614
[TBL] [Abstract][Full Text] [Related]
6. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.
Bruck N; Suttorp M; Kabus M; Heubner G; Gahr M; Pessler F
J Clin Rheumatol; 2011 Jan; 17(1):23-7. PubMed ID: 21169853
[TBL] [Abstract][Full Text] [Related]
7. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.
Shimizu M; Yokoyama T; Yamada K; Kaneda H; Wada H; Wada T; Toma T; Ohta K; Kasahara Y; Yachie A
Rheumatology (Oxford); 2010 Sep; 49(9):1645-53. PubMed ID: 20472718
[TBL] [Abstract][Full Text] [Related]
8. Perioperative anesthetic concerns in a child with systemic onset juvenile idiopathic arthritis syndrome.
Garg R; Hariharan UR; Sood R; Pawar M; Gupta A
Paediatr Anaesth; 2010 Aug; 20(8):773-5. PubMed ID: 20670244
[No Abstract] [Full Text] [Related]
9. A case of macrophage activation syndrome successfully treated with anakinra.
Kelly A; Ramanan AV
Nat Clin Pract Rheumatol; 2008 Nov; 4(11):615-20. PubMed ID: 18825135
[TBL] [Abstract][Full Text] [Related]
10. Recurrent macrophage activation syndrome associated with heterozygous perforin W374X gene mutation in a child with systemic juvenile idiopathic arthritis.
Unal S; Balta G; Okur H; Aytac S; Cetin M; Gumruk F; Ozen S; Gurgey A
J Pediatr Hematol Oncol; 2013 Jul; 35(5):e205-8. PubMed ID: 23274377
[TBL] [Abstract][Full Text] [Related]
11. [A case report of macrophage activation syndrome complicated by systemic onset juvenile idiopathic arthritis].
Zhao Y; Cao LF
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):610. PubMed ID: 18082055
[No Abstract] [Full Text] [Related]
12. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
Nádia EA; Carvalho JF; Bonfá E; Lotito AP; Silva CA
Isr Med Assoc J; 2009 Oct; 11(10):635-6. PubMed ID: 20077954
[No Abstract] [Full Text] [Related]
13. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
14. The incidence of macrophage activation syndrome in children with rheumatic disorders.
Moradinejad MH; Ziaee V
Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
[TBL] [Abstract][Full Text] [Related]
15. [Multi-organ failure as first clinical sign of macrophage activation syndrome in childhood Still's disease].
López-Sánchez M; Rubio-López I; Obeso-González T; Teja-Barbero JL; Santidrián-Miguel JP; Peiro-Callizo E
An Pediatr (Barc); 2010 Oct; 73(4):194-8. PubMed ID: 20643591
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis.
Ramanan AV; Rosenblum ND; Feldman BM; Laxer RM; Schneider R
J Rheumatol; 2004 Oct; 31(10):2068-70. PubMed ID: 15468377
[TBL] [Abstract][Full Text] [Related]
17. A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset still disease or systemic juvenile idiopathic arthritis sine arthritis?
Prendiville JS; Tucker LB; Cabral DA; Crawford RI
Pediatr Dermatol; 2004; 21(5):580-8. PubMed ID: 15461768
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.
Fall N; Barnes M; Thornton S; Luyrink L; Olson J; Ilowite NT; Gottlieb BS; Griffin T; Sherry DD; Thompson S; Glass DN; Colbert RA; Grom AA
Arthritis Rheum; 2007 Nov; 56(11):3793-804. PubMed ID: 17968951
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis.
Sawar H; Espinoza LR; Gedalia A
J Rheumatol; 2004 Mar; 31(3):623; author reply 623-4. PubMed ID: 14994420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
